With 7.84 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.07 million shares. During the session, the Software – Application company that operates in wider Technology sector, reached to the highest price of $2.2 whereas the lowest price it dropped to was $1.49. The 52-week range on RCT shows that it touched its highest point at $5.36 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $5.33.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of RCT was up-trending over the past week, with a rise of 119.93%, but this was down by -12.14% over a month. Three-month performance dropped to -44.14% while six-month performance fell -53.59%. A look at the trailing 12-month EPS for RCT yields -1.07 with Next year EPS estimates of 0.06. For the next quarter, that number is -0.06. This implies an EPS growth rate of 77.05% for this year and 117.91% for next year.
Float and Shares Shorts:
At present, 50.00 million RCT shares are outstanding with a float of 44.23 million shares on hand for trading. On 2025-09-15, short shares totaled 45955.0, which was 10.0 higher than short shares on 1755216000. In addition to Mr. Justin Beck Hinton Floyd as the firm’s Co-Founder, CEO & Director, Mr. Martin John Frost O.B.E. serves as its Co-Founder.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential. With RCT analysts setting a high price target of 5.0 and a low target of 5.0, the average target price over the next 12 months is 5.0. Based on these targets, RCT could surge 176.24% to reach the target high and rise by 176.24% to reach the target low. Reaching the average price target will result in a growth of 176.24% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.55255 being high and -$1.90745 being low. For RCT, this leads to a yearly average estimate of -$1.73.
